MedTrace Logo

Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor

NCT06119035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-02-02

No results posted yet for this study

Summary

The study aims to evaluate insulin as a potential biomarker for prediabetes in Singapore Chinese subjects.

Conditions

Interventions

OTHER

Single dose of 75 grams glucose in 200ml water

Consume single dose of 75 grams glucose in 200ml water

Sponsors & Collaborators

  • Institute for Human Development and Potential (IHDP), Singapore

    collaborator OTHER

  • Singapore Institute of Food and Biotechnology Innovation

    lead OTHER_GOV

Principal Investigators

  • James Chan, PhD · Singapore Institute of Food and Biotechnology Innovation (SIFBI), A*STAR

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-06
Primary Completion
2024-01-12
Completion
2024-01-12

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06119035 on ClinicalTrials.gov